The Summer 2026 IPO Class: What the First Form 4 Filings Show

Five notable companies went public inside five weeks this summer — a quantum computer maker, a record-setting biotech, a 248-year-old aerospace supplier, a tokenization platform, and SpaceX. Their first insider ownership filings are now on record, and they show something that doesn't happen often: executives, directors, and anchor investors putting in real money on day one.

At three new listings, insiders bought at the offer price

Quantinuum (QNT) priced an upsized $1.68 billion offering at $60 on June 4, with Honeywell (HON) keeping roughly 49% of the votes. Eleven insiders bought at exactly $60.00 in the first two days — about $25 million all told. Director Hal Barron put in $15 million, director Joseph Jimenez $4 million, and the buyer list includes Honeywell's own chief executive Vimal Kapur and Quantinuum's CFO Nitesh Sharan.

Doncasters (DPC) — the precision-parts maker founded in Sheffield in 1778, now supplying aerospace and turbine engine components — priced above range at $33 on June 24. Nine insiders bought $75.8 million at the offer, led by director Dirkson Charles at $36.8 million, with CEO Michael Quinn ($14.4 million) and CFO David Egan ($9.1 million) alongside.

Parabilis Medicines (PBLS) raised $670 million at $20 — the largest venture-backed biotech offering on record. Its biggest backer, RA Capital Management, added another $424 million at the offering and disclosed a 23.8% stake, while Regeneron (REGN) took a $75 million concurrent placement.

Offer-price purchases are typically arranged through the deal rather than picked up in the open market. It's still their own capital going in at the debut price, disclosed the same way as any insider buy — and at these three listings it added up to more than half a billion dollars in week one.

SpaceX's first filings: nothing sold

At SpaceX (SPCX), the only insider on file so far is Elon Musk, and his filings are structural — share awards from February and the share-class conversions that accompanied the June 12 listing. The single sale on record is $1.2 million from early April, at $105.32 a share, before the $135 offer. Securitize, which arrived on the NYSE by SPAC merger on July 2, is only beginning to file.

A year down the road, the flow reverses

CoreWeave (CRWV), the class of 2025's biggest listing, shows the other end of the pipeline. Insiders and early backers sold a net $1.89 billion in April and another $1.51 billion in May — $3.4 billion out the door in two months, after the three quiet months that started the year. The largest single seller in May was Magnetar, CoreWeave's earliest institutional backer, at just over $1 billion, sold in the first week of the month mostly between $119 and $138 a share. Selling by the executive team was smaller — under half a billion dollars for the month — and much of it ran under pre-scheduled trading plans.

Put side by side, the two moments look like phases of the same lifecycle: buy-ins at the debut, then distribution by early backers once the stock has the scale and liquidity to absorb it. Neither is a verdict on the company. Both are worth watching.

Notes

Insider activity is from Form 4 filings via FilingFrog, de-duplicated and limited to open-market transactions; purchases made at the IPO price through directed or concurrent allocations are reported on the same forms as any insider buy. CoreWeave figures are open-market sells net of buys by transaction month, with July counted through the 15th. First filings referenced: Quantinuum June 4, Parabilis June 9, SpaceX June 11, Doncasters June 24, 2026. Per-company insider pages are available in the insider section; the first institutional owners of these listings are covered in our companion piece on SpaceX.